Novel Expression of Vascular Endothelial Growth Factor Receptor (VEGFR)-3 and VEGF-C on Corneal Dendritic Cells
- 1 July 2003
- journal article
- research article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 163 (1), 57-68
- https://doi.org/10.1016/s0002-9440(10)63630-9
Abstract
No abstract availableKeywords
Funding Information
- Massachusetts Lions Eye Research Fund
- Research to Prevent Blindness
- National Institutes of Health
This publication has 88 references indexed in Scilit:
- Molecular control of lymphangiogenesisBioEssays, 2002
- Lymphatic endothelial regulation, lymphoedema, and lymph node metastasisSeminars in Cell & Developmental Biology, 2002
- Draining Lymph Nodes of Corneal Transplant Hosts Exhibit Evidence for Donor Major Histocompatibility Complex (MHC) Class II–positive Dendritic Cells Derived from MHC Class II–negative GraftsThe Journal of Experimental Medicine, 2002
- VEGF‐C and VEGF‐D expression in neuroendocrine cells and their receptor, VEGFR‐3, in fenestrated blood vessels in human tissuesThe FASEB Journal, 2000
- Twenty-five–Year Panorama of Corneal ImmunologyCornea, 2000
- High and low doses of haptens dictate whether dermal or epidermal antigen‐presenting cells promote contact hypersensitivityEuropean Journal of Immunology, 1997
- Maturation and Migration of Cutaneous Dendritic Cells.Journal of Investigative Dermatology, 1995
- Studies of Contact Hypersensitivity Induction in Mice with Optimal Sensitizing Doses of HaptenJournal of Investigative Dermatology, 1993
- The surface phenotype of dendritic cells purified from mouse thymus and spleen: investigation of the CD8 expression by a subpopulation of dendritic cells.The Journal of Experimental Medicine, 1992
- The fine structure of growing corneal lymphatic vesselsThe Journal of Pathology, 1971